Matinas BioPharma Holdings, Inc.
$0.16
-$0.00 (-1.27%)
$0.15Day Range$0.16
Key Statistics
Market Cap
$2.43M
Shares Outstanding
14.7M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Jul 21, 2014
Round Lot
100
Locale
US
Trading Data
Day Open
$0.16
Day High
$0.16
Day Low
$0.15
Volume
674.3K
VWAP
$0.16
Prev Close
$0.17
Transactions
--
Acc. Volume
--
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
PHARMACEUTICAL PREPARATIONSSIC 28342 employees1545 ROUTE 206 SOUTH, BEDMINSTER, NJ, 07921908-484-8805IPO Jul 21, 2014US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001582554
- Composite FIGI
- BBG005WX2XG8
- Share Class FIGI
- BBG005WX2XH7
- Ticker Root
- MTNB
- SIC Code
- 2834
About Matinas BioPharma Holdings, Inc. (MTNB) Stock
Matinas BioPharma Holdings, Inc. (MTNB) closed the 2026-09-17 session at $0.16, down 1.27% versus the previous close (-0.00). The stock opened at $0.16 and traded between $0.15 and $0.16 during that session. Session trading volume was 674K shares. The volume-weighted average price (VWAP) is $0.16.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
Matinas BioPharma Holdings, Inc. has a market capitalization of $2.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MTNB is listed on the XASE exchange. The company employs approximately 2 people. Matinas BioPharma Holdings, Inc. is headquartered in BEDMINSTER, NJ. The recorded listing date is 2014-07-21.
On this page you can find market MTNB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.